-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals Prepays Debt in Full With $23.3 Million Payoff

PUBT·11/05/2026 21:12:29
Listen to the news
Acumen Pharmaceuticals Prepays Debt in Full With $23.3 Million Payoff
  • Acumen Pharmaceuticals prepaid all obligations under its K2 HealthVentures Loan Agreement for approximately $23.3 million on November 5, 2026, using cash on hand.
  • The payoff included outstanding principal, accrued interest, fees and expenses, including a $1.6 million final payment fee.
  • The Loan Agreement terminated, ending the lender's conversion right and releasing all liens and security interests.
  • The term loan had been scheduled to mature on November 1, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acumen Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070987), on November 05, 2026, and is solely responsible for the information contained therein.